Can the IFU be signed electronically?

Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent, attribution, and retention requirements are met and include any consumer disclosures required for patient-facing records.

Is notarization required for an IFU?

Typically no; IFUs are labeling documents and do not require notarization. If a procurement contract or local law asks for notarized attestations, follow the specific state or contract requirement and retain supporting documentation.

How do I correct an error after signing?

Create a signed amendment or corrected IFU with a new effective date and retain both versions. Maintain a change log showing approver, rationale, and version history to preserve auditability for inspections.

Who must retain IFU records?

Manufacturers must retain controlled copies and distribution logs; healthcare providers should keep copies accessible to clinical staff and quality teams for inspection and post-market surveillance.

How long must IFU records be kept?

Follow applicable rules: HIPAA-related records six years (45 CFR §164.530(j)), financial records three years (IRC §6501(a)), and industry-specific longer periods where required.

Are translations or localizations required?

Some jurisdictions or procurement contracts require translated IFUs. When translations are used, retain both original and certified translation and document the translator and review process.

Electronic Signature
Templates
Healthcare
Healthcare Non-Latex IFU

Healthcare Non-Latex IFU

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE NON-LATEX INSTRUCTIONS FOR USE (IFU)

This Instructions for Use (IFU) provides required indications, warnings, precautions, handling and storage information for the specified non-latex medical device or product. The person named below acknowledges receipt of these instructions and confirms understanding of the risks, limitations, and proper use of the device. This IFU does not substitute for institutional policies, clinical judgment, or device labelling supplied with the product.

Patient Information

Patient Name

Date of Birth:

Gender:

Medical Record #:

Address

Phone:

Emergency Contact:

Emergency Phone:

Device Identification

Device Name: Model/Ref:

Lot / Batch #: Serial #: Expiration Date:

Manufacturer / Supplier

Indications, Contraindications, and Intended Use

Indications: This device is intended for use as described by facility protocols and the device labelling. Indications include clinical applications where a non-latex device is required due to documented or suspected latex sensitivity, or when institutional non-latex policies apply.

Contraindications: Do not use this device when a specific component is contraindicated for the patient (for example, a known allergy to an identified non-latex material listed below). Consult clinical staff prior to use in patients with multiple material sensitivities.

Other Indications or Notes

Materials Statement & Allergy Information

Material Declaration: The device is manufactured and supplied as non-latex. No intentionally added natural rubber latex components are included in the finished device. The device may contain synthetic elastomers, thermoplastics, silicone, or other polymeric materials. Components are listed where applicable on the product label.

Important: Non-latex designation reduces the risk of Type I (immediate) hypersensitivity reactions to natural rubber latex but does not eliminate the risk of allergic reaction to alternative materials. Patients with known allergies to specific polymers or additives should inform clinical staff prior to use.

Known Latex Allergy

I have a documented or suspected latex allergy

I do not have a known latex allergy

If allergic, list known material allergies

Instructions for Use (Handling, Application, and Reprocessing)

Handling and Application:

Verify device identification, lot number and expiration prior to use.
Perform hand hygiene and use appropriate personal protective equipment as required by facility protocol.
Use the device only for the intended application described in device labelling and institutional guidelines.
Inspect device immediately before use. Do not use if packaging is compromised or device is damaged.

Reprocessing / Single-Use

Warnings, Precautions, and Limitations

Warnings: Failure to follow these instructions may result in patient harm. Do not use the device if patient has a known allergy to any material listed. Do not reuse single-use devices. Use of incompatible reprocessing methods may render the device unsafe.

Precautions: Use with caution in patients with compromised skin or mucous membranes. Monitor patients for signs of allergic reaction during and after use. In cases of suspected hypersensitivity, discontinue use immediately and follow institutional emergency protocols.

Limitations: The non-latex designation is based on manufacturing controls and component selection. It is not a guarantee against all allergic reactions. Clinical performance depends on correct use, proper handling, and adherence to reprocessing instructions where applicable.

Storage, Sterilization, and Disposal

Storage: Store in original packaging, in a cool, dry place away from direct sunlight. Maintain temperatures and humidity within ranges specified on product labelling.

Sterilization: If the device is supplied sterile, use sterile package only once and do not attempt to resterilize unless explicit reprocessing instructions are provided. If sterilization is required, follow validated institutional sterilization processes consistent with device labelling.

Disposal: Dispose of used devices in accordance with applicable local regulations and institutional policy for medical waste and sharps where applicable.

Regulatory and Liability Statements

Manufacturer Statement: The manufacturer represents that the device is produced under quality systems intended to control the use of natural rubber latex in production. This representation is provided to assist clinical decision-making but does not expand or alter the terms of purchase or warranty contained in the product labelling.

Limitation of Liability: To the fullest extent permitted by law, the manufacturer and supplier disclaim liability for injury resulting from misuse, alteration, or failure to follow instructions and warnings herein or in the device labelling. Clinical judgment and facility policies shall govern final decisions on device selection and use.

Acknowledgment and Authorization

By signing below, I acknowledge that I have received, read, and understand these Instructions for Use for the named device. I have had the opportunity to ask questions and have received satisfactory answers. I consent to the use of the specified non-latex device for the indicated clinical purpose, understanding the stated risks and limitations.

Authorization valid until (expiration date) Relationship to Patient (if signing as guardian or representative)

Patient Name:

Signature:

Relationship:

Date:

What the Healthcare Non-Latex IFU Is and When It Applies

The Healthcare Non-Latex IFU is a formal Instructions for Use document that accompanies non-latex medical devices, supplies, or components sold or deployed in clinical settings. It explains intended use, indications, contraindications, shelf life, storage and handling, inspection and disposal instructions, and any patient or clinician warnings. The IFU is intended for device manufacturers, clinical procurement teams, and point-of-care staff who must ensure devices are used safely and in compliance with federal and state requirements.

Why a Clear, Compliant Non-Latex IFU Matters

A concise, accurate IFU reduces risk of misuse, supports regulatory compliance, and documents the manufacturer’s safety instructions for clinicians and facilities. Clear IFUs limit adverse events, reduce liability exposure, and provide evidence of adequate labeling and training in audits and inspections.

Who Prepares and Who Uses the Healthcare Non-Latex IFU

The IFU serves both as an operational reference for caregivers and as a compliance record for manufacturers and health systems.

Clinicians and nursing staff who need point-of-care guidance for correct device selection and use.
Procurement and inventory managers responsible for stocking, labeling, and version control of devices.
Regulatory and compliance teams that must demonstrate accurate labeling and training materials during inspections.

Step-by-Step: Create, Review, and Approve a Non-Latex IFU

Follow a controlled authoring, review, and approval workflow to ensure accuracy and regulatory traceability.

01

Draft: Author IFU text using current device specifications.
02

Clinical Review: Obtain clinician and subject-matter sign-off on instructions.
03

Regulatory Review: Confirm labeling meets applicable standards and documentation requirements.
04

Finalize: Approve, sign, and publish the IFU with version and effective date.

How eSubmission and Distribution of the IFU Typically Works

Electronic workflows speed distribution and version control while preserving an audit trail required for quality systems and inspections.

Prepare File: Create a PDF/A or DOCX IFU that preserves layout and accessibility.
Add Fields: Insert fillable fields for lot, date, and signatures where needed.
Route: Send to reviewers and approvers with role-based routing.
Distribute: Publish to internal portals, attach to product shipments, or embed in electronic medical record systems.

Technical Considerations for eSubmission and Storage

Ensure chosen platform supports long-term storage, audit trails, and access controls for regulated healthcare records.

File Formats: PDF, DOCX, PDF/A
Integrations: Salesforce, NetSuite, Microsoft 365
Authentication: Email, SMS, or stronger MFA

Security and Compliance Essentials for IFU Records

Encryption: TLS 1.2/1.3 in transit

Data at Rest: AES-256 encrypted storage

HIPAA: BAA required for PHI handling

Audit Trails: Tamper-evident event history

Certifications: SOC 2 Type II, ISO 27001

21 CFR Part 11: Supports FDA record controls

Key Risks When the IFU Is Incorrect or Missing

Patient Harm: Clinical injury or adverse events

Regulatory Action: FDA inspection findings

HIPAA Exposure: Potential breach penalties 45 CFR §160–164

Product Liability: Increased litigation risk

Recall Complexity: Harder traceability and remediation

Contract Noncompliance: Purchasing agreement breaches

Common Mistakes to Avoid When Preparing an IFU

Using ambiguous clinical language that leads to inconsistent interpretation at the point of care.
Failing to include lot or batch identifiers, which impedes traceability and recall actions if needed.
Not versioning the IFU clearly, causing old instructions to remain in circulation and confusing staff.
Skipping interdisciplinary review (clinical, regulatory, quality), which increases the chance of regulatory findings.

Practical Tips for Accurate and Efficient IFU Production

Adopt a repeatable process with clear roles and quality controls to reduce review cycles and potential nonconformances.

Use controlled templates

Maintain approved IFU templates in your quality system to ensure consistent structure, required headings, and regulatory language across products.

Implement version control

Assign version numbers and effective dates, archive superseded IFUs, and ensure procurement only distributes the current release.

Include traceable identifiers

Always show lot/batch, manufacturing date, and unique identifiers to enable rapid correlation with production records.

Document approvals

Record reviewer names, roles, and approval timestamps; keep a signed record for audit readiness and CAPA support.

Core Components of a Professional Healthcare Non-Latex IFU

A complete IFU balances clinical clarity with regulatory and quality system requirements; include the following components for full coverage.

Identification

Product name, catalog and model numbers, lot or batch code, and manufacturing identifiers to ensure correct product identification.

Intended Use

Clear statement of intended clinical applications, patient populations, and settings to reduce off-label use risk.

Instructions

Stepwise preparation, application, maintenance, and disposal directions that clinicians can follow at the point of care.

Warnings

Contraindications, potential adverse effects, and necessary precautions written in plain language to support safe use.

Storage

Temperature, humidity, shelf-life, and reprocessing or sterilization instructions that preserve product performance.

Regulatory

Version, effective date, manufacturer contact details, and statement of compliance or standards referenced for audits.

eSignature Vendor Comparison Relevant to IFU Signing and Distribution

Pricing and feature availability vary by vendor and plan; signNow appears first in this comparison for neutral reference to core pricing and compliance capabilities.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About the Healthcare Non-Latex IFU

Answers cover common points about electronic signing, retention, corrections, and distribution so users can manage IFUs confidently.

Need help? Contact support

Can the IFU be signed electronically?
Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent, attribution, and retention requirements are met and include any consumer disclosures required for patient-facing records.
Is notarization required for an IFU?
Typically no; IFUs are labeling documents and do not require notarization. If a procurement contract or local law asks for notarized attestations, follow the specific state or contract requirement and retain supporting documentation.
How do I correct an error after signing?
Create a signed amendment or corrected IFU with a new effective date and retain both versions. Maintain a change log showing approver, rationale, and version history to preserve auditability for inspections.
Who must retain IFU records?
Manufacturers must retain controlled copies and distribution logs; healthcare providers should keep copies accessible to clinical staff and quality teams for inspection and post-market surveillance.
How long must IFU records be kept?
Follow applicable rules: HIPAA-related records six years (45 CFR §164.530(j)), financial records three years (IRC §6501(a)), and industry-specific longer periods where required.
Are translations or localizations required?
Some jurisdictions or procurement contracts require translated IFUs. When translations are used, retain both original and certified translation and document the translator and review process.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now